Plasma Therapy Market

The plasma therapy market is projected to expand from US$ 540.17 million in 2024 to US$ 1,308.43 million by 2031, with an estimated CAGR of 13.80% from 2025 to 2031.

Analyst's Perspective

The analysis of the plasma therapy market highlights key growth factors such as the increasing prevalence of orthopedic disorders, particularly among the elderly; a rise in joint and muscle injuries among athletes; and a growing demand for minimally invasive cosmetic treatments. Additionally, the ability to customize plasma therapies to meet individual patient needs is anticipated to create new trends in the market from 2022 to 2030.

Plasma therapy, also known as platelet-rich plasma (PRP) therapy, involves using blood plasma from individuals who have recovered from an illness to treat various medical conditions and promote healing. PRP treatments are utilized in orthopedics for joint injuries, in dermatology for skin rejuvenation, and in dentistry for tissue repair. The growth factors found in PRP effectively stimulate tissue regeneration, speeding up injury healing and enhancing aesthetic procedures.

Market Insights

Increasing Incidence of Orthopedic Disorders & Muscle Injuries and Growing Use of PRP in Aesthetic Treatments Drive Plasma Therapy MarketAccording to data from the World Health Organization (WHO) published in 2023, approximately 528 million people worldwide were living with osteoarthritis (OA) in 2019, marking a 113% increase since 1990. A December 2020 article in PubMed Central indicates that PRP has significant potential for tissue repair due to its rich content of growth factors and cytokines, which are essential for creating and regulating regenerative environments for both soft and hard tissues. PRP therapy can aid in the healing of bone fractures, ligament, muscle, and tendon injuries, peripheral nerve injuries, articular cartilage lesions, and osteoarthritis. Consequently, there is a strong demand for plasma therapies in orthopedic and tissue repair applications.

Furthermore, PRP is increasingly used in cosmetic procedures for skin rejuvenation, anti-aging, and other aesthetic applications. A review published in PubMed Central in November 2021 evaluated 73 studies, with 45 focusing on PRP monotherapy and 35 examining the effects of PRP combined with microneedling. The therapies were generally well-tolerated and effective across various skin types. Positive outcomes were reported for conditions such as skin rejuvenation, scar revision, alopecia, pigmentary disorders, lichen sclerosus, leprosy-induced peripheral neuropathy, plaque psoriasis, and nail disorders.

Thus, the application of PRP in cosmetic procedures significantly contributes to the growth of the plasma therapy market.

Future Trends

Emergence of Customization Options for Patient-Centric Therapies in the Plasma Therapy Market

Customized plasma therapy involves tailoring treatments to meet the specific needs of patients based on their medical conditions and genetic profiles. These customization efforts aim to enhance the effectiveness of plasma therapy by adjusting the composition of components like antibodies and proteins to better address the patient's health issues. Researchers and healthcare professionals are working to develop tailored plasma therapies for specific conditions such as autoimmune disorders, infectious diseases, and rare cancers. Companies like Regenexx and Bridging Biosciences offer highly pure and concentrated PRP that can be customized to ensure consistency in tissue healing and cell regeneration. The USA Medical Research Institute in Texas provides PRP TruDose therapy, which delivers personalized therapeutic doses for various chronic pain conditions, including musculoskeletal issues, LUPUS, food sensitivities, Lyme disease, and other degenerative diseases.

Strategic Insights

Report Segmentation and ScopeType-Based Insights

The plasma therapy market is categorized by type into pure PRP, leukocyte-rich PRP, pure platelet-rich fibrin, and leukocyte-rich fibrin. The pure platelet-rich fibrin segment held the largest market share in 2022 and is expected to exhibit the highest CAGR from 2022 to 2030. Leukocyte-rich PRP (LR-PRP) contains a higher concentration of neutrophils (white blood cells) than the baseline level and is often associated with pro-inflammatory effects. However, LR-PRP can also be beneficial in stimulating inflammation to indicate chronic conditions like tendinopathy.

Source-Based Insights

The plasma therapy market is divided into autologous and allogeneic sources, with the autologous segment leading the market in 2020.

Application-Based Insights

By application, the plasma therapy market is segmented into orthopedic conditions, dermatology, dental issues, and others. The dermatology segment accounted for the largest market share in 2022.

End User-Based Insights

In terms of end users, the plasma therapy market is classified into hospitals and clinics, research institutes, ambulatory surgical centers (ASCs), and others. The hospital segment held the largest market share in 2022 and is projected to achieve the highest CAGR from 2022 to 2030.

Plasma Therapy Market Report Scope Regional Analysis

North America led the plasma therapy market in 2022 and is expected to record the highest CAGR during 2022 to 2030. The North American market is segmented into the US, Canada, and Mexico, with the US holding the largest share of the global plasma therapy market. The growth in this region is driven by the increasing adoption of platelet-rich plasma (PRP) in orthopedic and cosmetic surgeries, rising investments in healthcare, a dynamic research and development environment, and USFDA approvals for select PRP therapies.

The report profiles key players in the global plasma therapy market, including BioLife Plasma Services, Takeda Pharmaceutical Company Limited, Biotest AG CSL Ltd., Grifols, S.A., Kedrion S.p.A, ImmunoTek Bio Centers, Bio Products Laboratory Ltd., China Biologic Products Holdings, Inc., Octapharma AG, and Origin, Inc. These leading companies are focused on expanding and diversifying their market presence and client base to capitalize on existing business opportunities.

Key Developments by Major Market Players:In March 2023, BioLife Plasma Services announced the opening of new plasma donation centers in West Springfield (Massachusetts) and Pearland (Texas), enhancing its business network.In February 2021, Atlas Health Medical Group introduced the SkinPen, a microneedling device that incorporates PRP for facelifts, which punctures the skin to stimulate an anti-aging response.In March 2020, Takeda Pharmaceutical Company Limited began developing an anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-Ig) to treat patients with severe COVID-19.